Novartis Compiles Mouse Avatar "Encyclopedia"

Cancer Discovery
|December 2, 2015
PubMed

Insights

Novartis created the PDX Encyclopedia, a collection of over 1,000 patient-derived tumor xenograft models for various cancers. This resource will enhance in vivo drug screening to improve cancer therapy development.

Area of Science:

  • Oncology
  • Translational Research
  • Drug Discovery

Background:

  • The PDX Encyclopedia comprises over 1,000 patient-derived tumor xenograft models.
  • These models represent a wide spectrum of common solid tumors.
  • This collection serves as a valuable resource for preclinical cancer research.

Discussion:

  • The PDX Encyclopedia facilitates in vivo drug screening.
  • These screens are designed to closely mimic human clinical trial conditions.
  • This approach aims to improve the profiling of candidate therapies.

Key Insights:

  • A large-scale, diverse collection of patient-derived tumor xenograft models has been established.
  • The PDX Encyclopedia enables advanced in vivo drug efficacy testing.
  • This resource is expected to accelerate the development of novel cancer treatments.

Outlook:

  • Future applications include high-throughput screening of potential cancer drugs.
  • The PDX Encyclopedia is poised to refine preclinical drug candidate evaluation.
  • This initiative supports the advancement of personalized oncology strategies.